{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "344",
                "350"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Acesan"
        },
        {
            "identifier": "T2",
            "position": [
                "351",
                "359"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "1 x50 mg"
        },
        {
            "identifier": "T3",
            "position": [
                "360",
                "383"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "Kontrola kardiologiczna"
        },
        {
            "identifier": "T4",
            "position": [
                "384",
                "403"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "za ok. 6-8 miesi\u0119cy"
        },
        {
            "identifier": "T5",
            "position": [
                "416",
                "467"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "Okresowa kontrola saturacji krwi metod\u0105 przezsk\u00f3rn\u0105"
        },
        {
            "identifier": "T6",
            "position": [
                "686",
                "732"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Wrodzona wada serca pod postaci\u0105 dwunap\u0142ywowej"
        },
        {
            "identifier": "T7",
            "position": [
                "735",
                "762"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "dwuodp\u0142ywowej prawej komory"
        },
        {
            "identifier": "T8",
            "position": [
                "765",
                "787"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "ubytkami przegrodowymi"
        },
        {
            "identifier": "T9",
            "position": [
                "790",
                "807"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "malpozycj\u0105 naczy\u0144"
        },
        {},
        {
            "identifier": "T10",
            "position": [
                "813",
                "846"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Przetrwa\u0142a \u017cy\u0142a g\u0142\u00f3wna g\u00f3rna lewa"
        },
        {
            "identifier": "T11",
            "position": [
                "860",
                "868"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "operacji"
        },
        {
            "identifier": "T12",
            "position": [
                "869",
                "901"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "przew\u0119\u017cenia pnia t\u0119tnicy p\u0142ucnej"
        },
        {
            "identifier": "T13",
            "position": [
                "904",
                "914"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "25.06.2010"
        },
        {
            "identifier": "T14",
            "position": [
                "929",
                "977"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "operacji typu dwukierunkowy Glenn ( obustronny )"
        },
        {
            "identifier": "T15",
            "position": [
                "980",
                "990"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "12.08.2011"
        },
        {
            "identifier": "T16",
            "position": [
                "1002",
                "1025"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "operacji metod\u0105 Fontana"
        },
        {
            "identifier": "T17",
            "position": [
                "1028",
                "1039"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "09.10.2013r"
        },
        {
            "identifier": "T18",
            "position": [
                "1202",
                "1208"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "ACesan"
        },
        {
            "identifier": "T19",
            "position": [
                "1451",
                "1457"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Acesan"
        },
        {
            "icd": "ICD10:Q20",
            "identifier": "N1",
            "referenced": "T6",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        },
        {
            "icd": "ICD10:Q21.0",
            "identifier": "N2",
            "referenced": "T8",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzykomorowej"
        },
        {
            "icd": "ICD10:Q20.3",
            "identifier": "N3",
            "referenced": "T9",
            "subtype": "Reference",
            "type": "N",
            "value": "Nieprawid\u00c5\u0082owe po\u00c5\u0082\u00c4\u0085czenia komorowo-t\u00c4\u0099tnicze"
        },
        {
            "icd": "ICD10:Z98.8",
            "identifier": "N4",
            "referenced": "T11",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne okre\u00c5\u009blone stany po zabiegach chirurgicznych"
        },
        {
            "icd": "ICD10:Q25.6",
            "identifier": "N5",
            "referenced": "T12",
            "subtype": "Reference",
            "type": "N",
            "value": "Zw\u00c4\u0099\u00c5\u00bcenie pnia p\u00c5\u0082ucnego"
        },
        {
            "icd": "ICD10:Z98.8",
            "identifier": "N6",
            "referenced": "T14",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne okre\u00c5\u009blone stany po zabiegach chirurgicznych"
        },
        {
            "icd": "ICD10:Z98.8",
            "identifier": "N7",
            "referenced": "T16",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne okre\u00c5\u009blone stany po zabiegach chirurgicznych"
        },
        {
            "arg1": "T4",
            "arg2": "T3",
            "identifier": "R1",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T13",
            "arg2": "T14",
            "identifier": "R3",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T15",
            "arg2": "T16",
            "identifier": "R4",
            "subtype": "Dat",
            "type": "R"
        },
        {
            "arg1": "T17",
            "arg2": "T18",
            "identifier": "R8",
            "subtype": "Dat",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 8 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nZalecenia\n------------------------------------------------\nPrzyjmowanie : Acesan 1 x50 mg\nKontrola kardiologiczna za ok. 6-8 miesi\u0119cy w Gda\u0144sku .\nOkresowa kontrola saturacji krwi metod\u0105 przezsk\u00f3rn\u0105.\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: |Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Wrodzona wada serca pod postaci\u0105 dwunap\u0142ywowej i dwuodp\u0142ywowej prawej komory z ubytkami przegrodowymi i malpozycj\u0105 naczy\u0144 .\\x0aPrzetrwa\u0142a \u017cy\u0142a g\u0142\u00f3wna g\u00f3rna lewa .\\x0aStan po operacji przew\u0119\u017cenia pnia t\u0119tnicy p\u0142ucnej ( 25.06.2010 ).\\x0aStan po operacji typu dwukierunkowy Glenn ( obustronny ) - 12.08.2011\\x0aStan po operacji metod\u0105 Fontana ( 09.10.2013r )\\x0a\\x0aQ20.1,Q20.3, Q21.0, Q21.1, Z98.8,\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nACesan\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka  8 letnia  w  stanie   dobrym  zosta\u0142a   przyj\u0119ta  do  Kliniki   celem przeprowadzenia  bada\u0144 \nOtrzymuje  Acesan\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia\n    WBC:5.97[10\\\\^3/ul]\n    RBC:5.00[10\\\\^6/ul]\n    HGB:13.5[g/dl]\n    HCT:39.1[%]\n    MCV:78.2[fl]\n    MCH:27.0[pg]\n    MCHC:34.5[g/dl]\n    PLT:267.0[10\\\\^3/ul]\n    RDW-SD:38.9[fl]\n    RDW-CV:13.8[%]\n    PDW:11.5[fl]\n    MPV:10.1[fl]\n    P-LCR:26.5[%]\n    PCT:0.3[%]\n    NEUTR#:2.48[10\\\\^3/ul]\n    NEUTR%:41.6[%]\n    LYMPH#:2.89[10\\\\^3/ul]\n    LYMPH%:48.4[%]\n    MONO#:0.41[10\\\\^3/ul]\n    MONO%:6.90[%]\n    EO#:0.14[10\\\\^3/ul]\n    EO%:2.30[%]\n    BASO#:0.05[10\\\\^3/ul]\n    BASO%:0.80[%]\n    NRBC %:0.20[%]\n    NRBC#:0.01[10\\\\^3/ul]\nABL Parametry krytyczne\n    pH:7.322\n    pCO2:51.1[mmHg]\n    BE:-0.60[mmol/L]\n    HCO3:25.7[mmol/L]\n    pO2:26.2[mmHg]\n    O2Sat:35.1[%]\n    Na - ABL:140[mmol/L]\n    K - ABL:4.2[mmol/L]\n    Cl - ABL:108[mmol/L]\n    Ca zj ABL:1.31[mmol/L]\n    Ht - ABL:42.4[%]\n    Hb ABL:13.8[g/dl]\n    FO2Hb:34.9[%]\n    FCOHb:0.2[%]\n    FMetHb:0.4[%]\n    FHbF - ABL:*[%]\n    GLU-ABL:97[mg/dl]\n    mleczany:10[mg/dl]\n    COMMENT_HL7:\nImmununochemia -Immulite: COMMENT_HL7:\nImmununochemia -Immulite: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nD-dimery t. ilo\u015bciowy: D-dimer:56.0[ng/ml]\nFibrynogen (F): FIB:2.26[g/L]\nAntytrombina III (ATIII): ATIII:103.0[%]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:36.3[s]\nINR: INR:1.5\nCzas protrombinowy (PT): PT:17.0[s]\nCzas trombinowy (TT): TT:16.6[s]\nAlbumina w surowicy: ALB -Sur:4.70[g/dl]\nKwas mlekowy: LAC:34.50[mg/dl]\nChol.HDL/chol.ca\u0142k.: HDL/C:0.31\nGGTP gammaglutamylotranspeptydaza: GGT:38.00[IU/L]\nFosfataza alkaliczna: AP:193.60[IU/L]\nLDH dehydrogenaza mleczanowa: LDH:520.00[IU/L]\nTriglicerydy: TRIG:60.00[mg/dl]\nCholesterol: CHOL:134.00[mg/dl]\nBilirubina noworodkowa (NBIL): NBIL:*[mg/dl]\nBilirubina po\u015brednia-niesprz\u0119\u017cona (Bu): Bu:0.70[mg/dl]\nBilirubina bezpo\u015brednia-sprz\u0119\u017cona (Bc): Bc:0.00[mg/dl]\nBilirubina ca\u0142kowita TBIL: TBIL:0.90[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:65[%]\nBia\u0142ko ca\u0142kowite: TP:7.70[g/dl]\nKreatynina: CREA:0.50[mg/dl]\nMocznik: UREA:30.00[mg/dl]\nCholesterol LDL (met.bezpo\u015brednia): LDL:92.00[mg/dl]\nCholesterol HDL: HDL:42.00[mg/dl]\nASPAT: AST:30.00[IU/L]\nALAT: ALT:27.00[IU/L]\nNT- proBNP: NTpBNP:85.50[pg/ml]\nAFP: AFP:1.65[IU/ml]\nTSH: TSH:3.42[uIU/ml]\nPLT z ThromboExactu: PLT-THEX:261.0[10\\\\^3/ul]\nGlukoza w surowicy: GLU-sur:81[mg/dl]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:103.3[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:125[cm]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:137.5[ml/min/1,73m2]\nFT3 III: FT3 III:3.47[pg/ml]\nFT4II: FT4II:1.39[ng/dl]\nWITAMINA D\n    WIT D:27.2[ng/ml]\n    COMMENT_HL7:\n------------------------------------------------\nICD10\n------------------------------------------------\nQ20.3\nZ98.8\nQ20.1\nQ21.0\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\nO69\nG21\nG25\n89.541\nL69\n88.761\n------------------------------------------------"
}